1. FERRAN NAVARRO-BELTRAN, Film director. - faces.x.places
Missing: tit | Show results with:tit
Berlin in spring-summer and Barcelona in autumn-winter.
2. Integrative pathway enrichment analysis of multivariate omics data
This corrects the article "Integrative pathway enrichment analysis of multivariate omics data" in volume 11, 735.
. 2022 Dec 8;13:7570. doi: 10.1038/s41467-022-32342-9
3. [PDF] EMBO Facts & figures with annual report 2021
Oct 2, 2022 · 224 postdoctoral fellowships, 202 scientific exchange grants, and three core facility fellowships were awarded in 2021.
4. Author Correction: Analyses of non-coding somatic drivers ... - Nature
Jan 25, 2023 · The original Article has been corrected to include the members and affiliations of the PCAWG Consortium in the main paper.
Nature - Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
5. Pan-cancer analysis of whole genomes - PMC - PubMed Central
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled systematic documentation of this variation at the ...
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled systematic documentation of this variation at the whole-genome scale1–3. Here we report the integrative analysis of 2,658 whole-cancer genomes and their ...
See AlsoApartments for Rent in Utrecht
6. [PDF] List of Non-Compliant Entities Listado de Entidades Fuera de Cumplimiento
... BELTRAN ELECTRONIC LLC. 2018, 2019, 2020, 2021, 2022. 433727. BEMBA COLORÁ ... NAVARRO CORP. 2020, 2021. 429566. EMPRESAS NIEVES CORP. 2019, 2021, 2022.
7. The evolutionary history of 2658 cancers - Nature
Feb 5, 2020 · Sergi Beltran, Ivo G. Gut, Marta Gut, Simon C. Heath, Tomas Marques-Bonet, Arcadi Navarro, Miranda D. Stobbe, Jean-Rémi Trotta & Justin P ...
Cancer develops through a process of somatic evolution1,2. Sequencing data from a single biopsy represent a snapshot of this process that can reveal the timing of specific genomic aberrations and the changing influence of mutational processes3. Here, by whole-genome sequencing analysis of 2,658 cancers as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA)4, we reconstruct the life history and evolution of mutational processes and driver mutation sequences of 38 types of cancer. Early oncogenesis is characterized by mutations in a constrained set of driver genes, and specific copy number gains, such as trisomy 7 in glioblastoma and isochromosome 17q in medulloblastoma. The mutational spectrum changes significantly throughout tumour evolution in 40% of samples. A nearly fourfold diversification of driver genes and increased genomic instability are features of later stages. Copy number alterations often occur in mitotic crises, and lead to simultaneous gains of chromosomal segments. Timing analyses suggest that driver mutations often precede diagnosis by many years, if not decades. Together, these results determine the evolutionary trajectories of cancer, and highlight opportunities for early cancer detection. Whole-genome sequencing data for 2,778 cancer samples from 2,658 unique donors across 38 cancer types is used to reconstruct the evolutionary history of cance...
8. New Insights and Potential Therapeutic Interventions in ... - MDPI
Additionally, single-cell transcriptomics can provide a more detailed picture of the expression of metabolic genes in response to disease [166]. Finally, single ...
Endocrine homeostasis and metabolic diseases have been the subject of extensive research in recent years. The development of new techniques and insights has led to a deeper understanding of the mechanisms underlying these conditions and opened up new avenues for diagnosis and treatment. In this review, we discussed the rise of metabolic diseases, especially in Western countries, the genetical, psychological, and behavioral basis of metabolic diseases, the role of nutrition and physical activity in the development of metabolic diseases, the role of single-cell transcriptomics, gut microbiota, epigenetics, advanced imaging techniques, and cell-based therapies in metabolic diseases. Finally, practical applications derived from this information are made.
9. Molecular signaling and chromatin – Marian Martínez - IBMB CSIC
Vicioso-Mantis M *, Fueyo R*, Navarro C, Cruz-Molina S, van Ijcken W FJ ... Estarás C, Fueyo R, Akizu N, Beltrán S, and Martínez-Balbás MA. (2013) RNA ...
All the Information about Molecular Signaling and Chromatin Research Group of The Institute of Molecular Biology of Barcelona (IBMB).
